Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 62

Results For "research"

2025 News Found

Pigeon Singapore, LyondellBasell collaborate to incorporate bio-circular plastic in nursing bottles
Healthcare | December 26, 2023

Pigeon Singapore, LyondellBasell collaborate to incorporate bio-circular plastic in nursing bottles

The LyondellBasell CirculenRenew polymers are made from renewable feedstocks derived from bio-based wastes


GenSci launches global innovation hub in Shanghai
News | December 26, 2023

GenSci launches global innovation hub in Shanghai

The establishment of the facility demonstrates the company's commitment to delivering differentiated solutions to gynecology and pediatrics challenges


Roche receives USFDA’s priority review to Xolair for food allergies based on positive NIH Phase III study results
Drug Approval | December 26, 2023

Roche receives USFDA’s priority review to Xolair for food allergies based on positive NIH Phase III study results

If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure


Wainua granted first-ever regulatory approval in the US for improving neuropathy impairment
Drug Approval | December 26, 2023

Wainua granted first-ever regulatory approval in the US for improving neuropathy impairment

US FDA approval based on NEURO-TTRansform Phase III results


Ind-Swift Laboratories receives award from World HRD Congress
News | December 25, 2023

Ind-Swift Laboratories receives award from World HRD Congress

World HRD Congress is a well-known international body of Management Studies


USFDA grants priority review for Patritumab Deruxtecan in US for certain patients with EGFR-mutated non-small cell lung cancer
Drug Approval | December 23, 2023

USFDA grants priority review for Patritumab Deruxtecan in US for certain patients with EGFR-mutated non-small cell lung cancer

If approved, patritumab deruxtecan would be a first-in-class HER3 directed DXd antibody drug conjugate for these patients


Digital transformation key to managing rising organisational healthcare costs in India
Digitisation | December 22, 2023

Digital transformation key to managing rising organisational healthcare costs in India

Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024


FDA grants priority review to Merck’s new biologics license application for V116
Drug Approval | December 20, 2023

FDA grants priority review to Merck’s new biologics license application for V116

V116 is an investigational, 21-valent pneumococcal conjugate vaccine specifically designed to protect adults


Zydus receives USFDA approval USFDA to initiate Phase II clinical trial of ZYIL1 for Parkinson's disease
Drug Approval | December 18, 2023

Zydus receives USFDA approval USFDA to initiate Phase II clinical trial of ZYIL1 for Parkinson's disease

Studies have demonstrated that ZYIL1 is highly potent and can suppress inflammation caused by NLRP3 inflammasome activation


Biocon Biologics recognized as an Asia IP Elite for 2023
News | December 17, 2023

Biocon Biologics recognized as an Asia IP Elite for 2023

Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list